<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045029"><TermName>atrasentan</TermName><TermPronunciation>(A-truh-SEN-tan)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000728247" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;atrasentan&quot;" language="en" id="_3"/><MediaLink ref="CDR0000728246" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;atrasentan&quot;" language="es" id="_4"/><SpanishTermName>atrasentán</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de antagonista del receptor de la proteína endotelina-1.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2003-10-15</DateLastModified></GlossaryTerm>
